Correlation Between CTi Biopharma and Reviva Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both CTi Biopharma and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTi Biopharma and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CTi Biopharma Corp and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on CTi Biopharma and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTi Biopharma with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTi Biopharma and Reviva Pharmaceuticals.

Diversification Opportunities for CTi Biopharma and Reviva Pharmaceuticals

-0.34

Correlation Coefficient

CTi Biopharma  Reviva Pharmaceuticals

Very good diversification

The 3 months correlation between CTi and Reviva is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding CTi Biopharma Corp and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and CTi Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTi Biopharma Corp are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of CTi Biopharma i.e., CTi Biopharma and Reviva Pharmaceuticals go up and down completely randomly.

Pair Corralation between CTi Biopharma and Reviva Pharmaceuticals

If you would invest  125.00  in Reviva Pharmaceuticals Holdings on September 4, 2024 and sell it today you would lose (7.00) from holding Reviva Pharmaceuticals Holdings or give up 5.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

CTi Biopharma Corp  vs.  Reviva Pharmaceuticals Holding

CTi Biopharma Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CTi Biopharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, CTi Biopharma is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Reviva Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Reviva Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with CTi Biopharma and Reviva Pharmaceuticals

The main advantage of trading using opposite CTi Biopharma and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTi Biopharma position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.

The idea behind CTi Biopharma Corp and Reviva Pharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.